Search Results - "Parnitzke, Ulrike"

Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma by Streubel, Gundula, Schrepfer, Sabine, Kallus, Hannah, Parnitzke, Ulrike, Wulff, Tanja, Hermann, Frank, Borgmann, Matthias, Hamm, Svetlana

“…In hepatocellular carcinoma (HCC), blood platelets have been linked to tumor growth, epithelial-to-mesenchymal transition (EMT), extrahepatic metastasis and a…”
Get full text

Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME) by Bretz, Anne Catherine, Parnitzke, Ulrike, Kronthaler, Kerstin, Dreker, Tobias, Bartz, René, Hermann, Frank, Ammendola, Astrid, Wulff, Tanja, Hamm, Svetlana

“…BackgroundThe efficacy of PD-(L)1 blockade depends on the composition of the tumor immune microenvironment (TIME) and is generally higher in tumors with…”
Get full text

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts by Carbone, David, Sharpnack, Michael, He, Kai, Butterfield, Lisa H., Eggermont, Alexander M. M., Gonzalez-Cao, Maria, Karachaliou, Niki, Crespo, Guillermo, Aldeguer, Erika, Drozdowskyj, Ana, Giménez-Capitán, Ana, Teixidó, Cristina, Molina-Vila, Miguel Angel, Ramírez, Santiago Viteri, Algarra, Salvador Martin, Pérez-Ruiz, Elisabeth, Márquez-Rodas, Iván, Rodriguez-Abreu, Delvys, Blanco, Remei, Puértolas, Teresa, Royo, Maria Angeles, Rosell, Rafael, Ascierto, Maria Libera, Hamm, Svetlana, Wulff, Tanja, Kronthaler, Kerstin, Schrepfer, Sabine, Parnitzke, Ulrike, Bretz, Anne Catherine, Baumgartner, Roland, Ferrucci, Veronica, Pennino, Francesco Paolo, Dassi, Luisa, Asadzadeh, Fatemeh, Siciliano, Roberto, Carotenuto, Marianeve, Spano, Daniela, Chiarolla, Cristina Maria, Greco, Adelaide, Cantile, Monica, Di Bonito, Maurizio, Botti, Gerardo, Jonathan, Vandenbussche, Kris, Gevaert, Zollo, Massimo, Amaral, Teresa, Tampouri, Ioanna, Keim, Ulrike, Eigentler, Thomas, Garbe, Claus, Forschner, Andrea, Cesano, Alessandra, Warren, Sarah, Moogk, Duane, Li, Kaitao, Yuan, Zhou, Zhong, Shi, Yu, Zhiya, Liadi, Ivan, Rittase, William, Fang, Victoria, Dougherty, Janna, Perez-Garcia, Arianne, Osman, Iman, Varadarajan, Navin, Restifo, Nicholas P., Frey, Alan, Zhu, Cheng, Krogsgaard, Michelle, Vanpouille-Box, Claire, Formenti, Silvia C., Demaria, Sandra, Nigro, Cristiana Lo, Renziehausen, Alexander, Tzakos, Andreas G., Wang, Hexiao, Rao, Bhavya, Matin, Rubeta, Harwood, Catherine, Vivenza, Daniela, Tonissi, Federica, Occelli, Marcella, Weir, Lynda, Li, Su, Sim, Van Ren, O’Neill, Kevin, Evans, Alan, Thompson, Alastair, Szlosarek, Peter, Fleming, Colin, Proby, Charlotte, Syed, Nelofer, Merlano, Marco, Crook, Tim, Ferguson, Robert, Simpson, Danny, Martinez, Carlos, Vogelsang, Matjaz, Kazlow, Esther, Wilson, Melissa

Get full text

Resminostat affects transcriptional regulation of disease-related processes in CTCL by Bretz, Anne Catherine, Parnitzke, Ulrike, Borgmann, Matthias, Hamm, Svetlana

Get full text

Mode-of-action of HDAC inhibitor resminostat in CTCL by Streubel, Gundula, Bretz, Anne Catherine, Wulff, Tanja, Parnitzke, Ulrike, Kallus, Hannah, Kronthaler, Kerstin, Borgmann, Matthias, Hamm, Svetlana

Get full text

Abstract 3088: Combination of 4SC-202 and IFN-γ restores mature APC phenotype in AML cells by Bretz, Anne Catherine, Parnitzke, Ulrike, Kronthaler, Kerstin, Hamm, Svetlana

“…Acute myeloid leukemia (AML) is characterized by a differentiation block resulting in accumulation of immature myeloid cells. Differentiation therapy, e.g…”
Get full text

Abstract 4722: 4SC-202 increases immunogenicity of tumor cells, induces infiltration of tumor microenvironment with cytotoxic T cells, and primes tumors for combinations with different cancer immunotherapy approaches by Hamm, Svetlana, Wulff, Tanja, Kronthaler, Kerstin, Schrepfer, Sabine, Parnitzke, Ulrike, Bretz, Anne Catherine, Bartz, René

“…Various histone deacetylases (HDAC) inhibitors were described as beneficially affecting anti-tumoral immune response. Although different HDAC inhibitors were…”
Get full text

Resminostat plus sorafenib in hepatocellular carcinoma (HCC) as apotential new treatment approach in platelet-driven solid tumors by Hermann, Frank, Streubel, Gundula, Schrepfer, Sabine, Parnitzke, Ulrike, Krauss, Rolf, Borgmann, Matthias, Hamm, Svetlana

“…Abstract only…”
Get full text

Abstract 2632: 4SC-202 induces inflamed tumor microenvironment, strongly enhances tumor infiltration with cytotoxic T cells and primes tumors for anti-PD1/PD-L1 therapy by Wulff, Tanja, Kronthaler, Kerstin, Schrepfer, Sabine, Parnitzke, Ulrike, Bretz, Anne Catherine, Baumgartner, Roland, Hamm, Svetlana

“…Various HDAC inhibitors were described as beneficially affecting anti-tumoral immune response. Although different HDAC inhibitors were investigated in…”
Get full text